ECSP982542A - Nuevo metodo de tratamiento iii - Google Patents
Nuevo metodo de tratamiento iiiInfo
- Publication number
- ECSP982542A ECSP982542A ECSP982542A ECSP982542A EC SP982542 A ECSP982542 A EC SP982542A EC SP982542 A ECSP982542 A EC SP982542A EC SP982542 A ECSP982542 A EC SP982542A
- Authority
- EC
- Ecuador
- Prior art keywords
- new method
- treatment iii
- treatment
- mammal
- diabetes mellitus
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 241000124008 Mammalia Species 0.000 abstract 2
- 206010012601 diabetes mellitus Diseases 0.000 abstract 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención se refiere a un método para el tratamiento de diabetes mellitus y procesos asociados a la diabetes mellitus en un mamífero, cuyo método comprende administrar una cantidad eficaz, no tóxica y farmacéuticamente eficaz de compuesto (I) e insulina a un mamífero con necesidad de ello.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982542 ECSP982542A (es) | 1998-06-17 | 1998-06-17 | Nuevo metodo de tratamiento iii |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982542 ECSP982542A (es) | 1998-06-17 | 1998-06-17 | Nuevo metodo de tratamiento iii |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP982542A true ECSP982542A (es) | 1999-02-11 |
Family
ID=42043462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP982542 ECSP982542A (es) | 1998-06-17 | 1998-06-17 | Nuevo metodo de tratamiento iii |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP982542A (es) |
-
1998
- 1998-06-17 EC ECSP982542 patent/ECSP982542A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA02012763A (es) | Combinaciones de inhibidores de dipeptidil peptidasa iv y otros agentes antidiabeticos para el tratamiento de diabetes mellitus. | |
| WO2000066142A3 (en) | Metabolic intervention with glp-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain | |
| MXPA05007470A (es) | Metodo para reducir la morbilidad y mortalidad cardiovascular en pacientes prediabeticos y pacientes con diabetes de tipo 2. | |
| WO2004050115A3 (en) | Combination treatment using exendin-4 and thiazolidinediones | |
| EA200100289A1 (ru) | Способ введения инсулинотропных пептидов | |
| BR0308904A (pt) | Método de tratamento de gastroparesia, e, uso de um composto de glp-1 | |
| EA200300026A1 (ru) | Аналоги глюкагоноподобного пептида-1 | |
| WO2002018327A3 (en) | Guanidinobenzamides as mc4-r agonists | |
| AP2001002291A0 (en) | Novel method of treatment. | |
| ATE348630T1 (de) | Verminderung der nebenwirkungen der chemotherapie in krebspatienten | |
| PL373361A1 (en) | Erythropoietin ameliorates chemotherapy-induced toxicity in vivo | |
| CA2296653A1 (en) | Treatment of diabetes with thiazolidinedione, insulin secretagogue and biguanide | |
| CO4940454A1 (es) | Nuevo metodo de tratamiento | |
| MY138246A (en) | Treatment of diabetes with thiazolidione and sulphonylurea. | |
| AR019724A2 (es) | Composicion farmaceutica util para el tratamiento de diabetes mellitus y condiciones asociadas | |
| MY125855A (en) | Treatment of diabetes with a thiazolidinedione and sulphonylurea | |
| AP9901720A0 (en) | Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitors. | |
| ECSP982542A (es) | Nuevo metodo de tratamiento iii | |
| ECSP982534A (es) | Nuevo metodo de tratamiento | |
| MXPA02012315A (es) | Compuesto farmaceutico que contiene silimarina y carbopol, su proceso de fabricacion y su uso como regenerador del tejido y celulas pancreaticas de secrecion endogena danados por diabetes mellitus. | |
| WO2001047509A3 (en) | Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions | |
| ECSP982593A (es) | Nuevo metodo de tratamiento vi | |
| ECSP982541A (es) | Nuevo metodo de tratamiento ii | |
| CO5150158A1 (es) | Tratamiento antidiabetico novedoso | |
| ECSP982535A (es) | Nuevo metodo de tratamiento (i) |